Cleerly
SF 8.2Coronary plaque analytics from CT angiography
Coronary plaque analytics from CT angiography
AI echocardiography for heart failure evaluation
Quick decision guide
Not enough differentiated product data yet to make a strong automatic pick.
Overview
Cleerly is an AI-driven coronary artery disease imaging platform for cardiology programs, analyzing coronary CT angiography to characterize plaque, stenosis, and atherosclerosis risk.
A focused pilot can establish clinical workflow fit and implementation needs before a wider rollout.
Ultromics is an AI echocardiography platform for cardiology services, analyzing cardiac ultrasound images to support heart failure assessment, imaging review, and risk stratification.
Ultromics is best evaluated as a specialist echocardiography layer whose value depends on clinical oversight, workflow integration, and local clearance.
Side-by-side
OVERLAP
Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.
Shared capabilities
Shared workflows
Feature check
The trade-offs
Final verdict
Current catalog data shows meaningful overlap between Cleerly and Ultromics. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.
Cleerly and Ultromics share 9 catalog signals, so the decision should focus on fit rather than broad capability alone.
Cleerly has 3 visible decision signals and Ultromics has 3.
Cleerly has the higher SoftFinders Score in the current catalog data.